Compare ABUS & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABUS | FMNB |
|---|---|---|
| Founded | 2005 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 839.5M | 857.4M |
| IPO Year | 2008 | 2010 |
| Metric | ABUS | FMNB |
|---|---|---|
| Price | $4.68 | $16.31 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.3M | 415.5K |
| Earning Date | 05-14-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 4.89% |
| EPS Growth | ★ 55.26 | 18.85 |
| EPS | ★ 0.84 | 0.76 |
| Revenue | $14,083,000.00 | ★ $279,922,000.00 |
| Revenue This Year | N/A | $52.63 |
| Revenue Next Year | $239.71 | $8.28 |
| P/E Ratio | ★ $5.45 | $21.55 |
| Revenue Growth | ★ 128.21 | 3.89 |
| 52 Week Low | $3.35 | $12.23 |
| 52 Week High | $5.38 | $16.39 |
| Indicator | ABUS | FMNB |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 69.98 |
| Support Level | $4.11 | $13.75 |
| Resistance Level | $4.82 | N/A |
| Average True Range (ATR) | 0.15 | 0.26 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 92.39 | 86.19 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Farmers National Banc Corp is a financial holding company based in the U.S. Along with its subsidiaries, it operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The group offers a full range of commercial and retail banking services, including checking accounts, savings accounts, time deposit accounts, commercial, mortgage, and installment loans, safe deposit boxes, ATMs, internet banking, and other banking services. Additionally, it offers personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; insurance products, and other financial products and services. The group's reportable segments are Bank, which generates the maximum revenue, and Trust.